Augurex Life Sciences Corp. develops biomarkers, which are substances that indicate what is going on in the body, thereby making them useful for diagnosing and managing patients’ diseases through the use of simple blood tests. Our lead biomarker, AGX-020, is being developed as a first-in-kind biomarker for arthritis management to help physicians accurately measure the degree of disease activity, determine patients’ response to biological therapy and differentiate between certain forms of arthritis.